Somatic hypermutation shapes the viral escape profile of SARS-CoV-2 neutralising antibodiesResearch in context
Summary: Background: Since the onset of the COVID-19 pandemic, SARS-CoV-2 neutralising monoclonal antibodies (mAbs) are being developed for clinical use. With the appearance of new virus variants, most mAbs lost their virus-neutralising activity, highlighting the complexity of mAb development under...
Saved in:
| Main Authors: | Matthias Bruhn, Maureen Obara, Mariana Gonzalez-Hernandez, Wencke Reineking, Abdus Salam, Monica Mirolo, Imke Hinrichs, AhmedElmontaser Mergani, Yannic Bartsch, Axel Schambach, Gert Zimmer, Wolfgang Baumgärtner, Albert D.M.E. Osterhaus, Ulrich Kalinke |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | EBioMedicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396425002142 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transposon insertion sequencing reveals novel hypermutator genes in Acinetobacter baumannii
by: Francesca L. Short, et al.
Published: (2025-08-01) -
Association between somatic microsatellite instability, hypermutation status, and specific T cell subsets in colorectal cancer tumors
by: Claire E. Thomas, et al.
Published: (2024-12-01) -
The SV40 virus enhancer functions as a somatic hypermutation-targeting element with potential tumorigenic activity
by: Filip Šenigl, et al.
Published: (2024-12-01) -
Large-scale computational modelling of H5 influenza variants against HA1-neutralising antibodiesResearch in context
by: Colby T. Ford, et al.
Published: (2025-04-01) -
Systematic evaluation of intratumoral and peripheral BCR repertoires in three cancers
by: Sofia V Krasik, et al.
Published: (2025-01-01)